ArticleLeukemia2026
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms.
Abstract readLetter
In one paragraph
Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors.
Kelly S ChienDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kchien@mdanderson.org.ORCID http://orcid.org/0000-0001-6024-1613
Ziyi LiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Luca LaninoHematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-2404-8829
Najla Al AliDepartment of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
Samuel UrrutiaDivision of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alex BatallerDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6085-2745
Rashmi Kanagal-ShamannaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7829-5249
Sanam LoghaviDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8980-3202
Yue LyuDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8912-6624
Ahmed AbdelhakeemDivision of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0001-7186-1332
Tareq AbuasabDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0009-0008-9205-6867
Emmanuel AlmanzaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9697-8879
Georgina Gener RicosDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alexandre BazinetDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5538-4943
Alessia CampagnaIRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Giulia MaggioniIRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Eric PadronDepartment of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-4707-7916
Zhouer XieDepartment of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-1266-9804
Guillermo Montalban-BravoDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4533-5176
Nicholas J ShortDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-2983-2738
Elias J JabbourDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4465-6119
Tapan M KadiaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9892-9832
Farhad RavandiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-7621-377X
Gautam BorthakurDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7679-6453
Courtney D DiNardoDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9003-0390
Danielle HammondDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6017-2264
Mahesh SwaminathanDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5959-397X
Koji SasakiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9140-0610
Xiao Qin DongDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sherry A PierceDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David SallmanDepartment of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-0504-8233
Hagop M KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1908-3307
Matteo G Della PortaIRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID http://orcid.org/0000-0002-6915-5970
Guillermo Garcia-Manero *Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-3631-2482
Rami Komrokji *Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-1876-5269
Funding
UT | University of Texas MD Anderson Cancer Center (MD Anderson) MDS/AML Moon ShotUT | University of Texas MD Anderson Cancer Center (MD Anderson) Support Grant CA016672
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
41792442What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.